IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates

被引:169
作者
Picker, Louis J.
Reed-Inderbitzin, Edward F.
Hagen, Shoko I.
Edgar, John B.
Hansen, Scott G.
Legasse, Alfred
Planer, Shannon
Piatak, Michael, Jr.
Lifson, Jeffrey D.
Maino, Vernon C.
Axthelm, Michael K.
Villinger, Francois
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Oregon Hlth & Sci Univ, Dept Pathol, Beaverton, OR 97006 USA
[3] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA
[4] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA
[5] SAIC Frederick Inc, NCI, AIDS Vaccine Program, Frederick, MD 21701 USA
[6] BD Biosci, San Jose, CA USA
[7] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1172/JCI27564
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
HIV infection selectively targets CD4(+) effector memory T (T-EM) cells, resulting in dramatic depletion of CD4(+) T cells in mucosal effector sites in early infection. Regeneration of the TEM cell compartment is slow and incomplete, even when viral replication is controlled by antiretroviral therapy (ART). Here, we demonstrate that IL-15 dramatically increases in vivo proliferation of rhesus macaque (RM) CD4(+) and CD8(+) TEM cells with little effect on the naive or central memory T (T-CM) cell subsets, a response pattern that is quite distinct from that of either IL-2 or IL-7. T-EM cells produced in response to IL-15 did not accumulate in blood. Rather, 5-bromo-2'-deoxyuridine (BrdU) labeling studies suggest that many of these cells rapidly disperse to extralymphoid effector sites, where they manifest (slow) decay kinetics indistinguishable from that of untreated controls. In RMs with uncontrolled SIV infection and highly activated immune systems, IL-15 did not significantly increase CD4(+) T-EM cell proliferation, but with virologic control and concomitant reduction in immune activation by ART, IL-15 responsiveness was again observed. These data suggest that therapeutic use of IL-15 in the setting of ART might facilitate specific restoration of the CD4(+) T cell compartment that is the primary target of HIV with less risk of exhausting precursor T cell compartments or generating potentially deleterious regulatory subsets.
引用
收藏
页码:1514 / 1524
页数:11
相关论文
共 49 条
  • [1] IL-15 and HIV infection: Lessons for immunotherapy and vaccination
    Ahmad, A
    Ahmad, R
    Iannello, A
    Toma, E
    Morisset, R
    Sindhu, STAK
    [J]. CURRENT HIV RESEARCH, 2005, 3 (03) : 261 - 270
  • [2] IL-7 and IL-15:: therapeutic cytokines for immunodeficiency
    Alpdogan, Ö
    van den Brink, MRM
    [J]. TRENDS IN IMMUNOLOGY, 2005, 26 (01) : 56 - 64
  • [3] CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    Brenchley, JM
    Schacker, TW
    Ruff, LE
    Price, DA
    Taylor, JH
    Beilman, GJ
    Nguyen, PL
    Khoruts, A
    Larson, M
    Haase, AT
    Douek, DC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) : 749 - 759
  • [4] Discovering the neural basis of human social anxiety: A diagnostic and therapeutic imperative
    Charney, DS
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (01) : 1 - 2
  • [5] Cline AN, 2005, J MED PRIMATOL, V34, P303
  • [6] T cell dynamics in HIV-1 infection
    Douek, DC
    Picker, LJ
    Koup, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 265 - 304
  • [7] Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection
    Farel, CE
    Chaitt, DG
    Hahn, BK
    Tavel, JA
    Kovacs, JA
    Polis, MA
    Masur, H
    Follmann, DA
    Lane, HC
    Davey, RT
    [J]. BLOOD, 2004, 103 (09) : 3282 - 3286
  • [8] FRY H, 2002, TEACH HIGH EDUC, V7, P99
  • [9] IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates
    Fry, TJ
    Moniuszko, M
    Creekmore, S
    Donohue, SJ
    Douek, DC
    Giardina, S
    Hecht, TT
    Hill, BJ
    Komschlies, K
    Tomaszewski, J
    Franchini, G
    Mackall, CL
    [J]. BLOOD, 2003, 101 (06) : 2294 - 2299
  • [10] Overview of interleukin-2 function, production and clinical applications
    Gaffen, SL
    Liu, KD
    [J]. CYTOKINE, 2004, 28 (03) : 109 - 123